The Trendlines Group Ltd. (SGX: 42T)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.0530
-0.0040 (-7.02%)
At close: Oct 11, 2024

The Trendlines Group Company Description

The Trendlines Group Ltd. is an innovation commercialization company and a private equity and venture capital firm specializing in incubation, seed, start-up, early venture and late venture investments.

The firm seeks to invest in food, clean technology, agritechnology, lifesciences with a focus on medical devices, biotechnology, and pharmaceuticals, security, medical, and information technology companies.

It considers investments in Israel and Singapore. The firm offers business incubation, partner and channel development, market strategies, business plans, research and development and commercialization activities, business development, finance and funding strategies, administrative services and marketing communications services to entrepreneurs.

The firm prefers to exit its investments through merger and acquisition transactions, listing on public stock exchanges, or other dispositions of holdings.

It leverages its own capital with government funding to mitigate risk in creating and developing new businesses.

It is involved in all aspects of its portfolio companies from technology development to business building.

The Trendlines Group Ltd. was founded in 1993 and is based in M.P. Misgav, Israel with additional offices in Tel Aviv, Israel; Beijing, China; and Singapore, Singapore.

The Trendlines Group Ltd.
Country Israel
Founded 1993
Industry Investors, not elsewhere classified
Employees 24
CEO Haim Brosh

Contact Details

Address:
The Trendlines Building
M P Misgav, 2017400
Israel
Phone 972 72 260 7000
Website trendlines.com

Stock Details

Ticker Symbol 42T
Exchange Singapore Exchange - Catalist
Fiscal Year January - December
Reporting Currency USD
SIC Code 6799

Key Executives

Name Position
Haim Brosh Chief Executive Officer
Haim Brosh Chief Financial Officer
Irit Shemesh-Catz Chief Operating Officer
Shira Zimmerman Head of Investor Relations